scholarly journals 873: SYMPTOM CONTROL AND METABOLOMICS OF DIAZEPAM, KETAMINE, AND DEXMEDETOMIDINE IN ALCOHOL WITHDRAWAL

2021 ◽  
Vol 50 (1) ◽  
pp. 432-432
Author(s):  
Robert MacLaren ◽  
Richard Radcliffe ◽  
Edward Van Matre ◽  
Scott Mueller ◽  
Nichole Reisdorph ◽  
...  
2001 ◽  
Vol 120 (5) ◽  
pp. A441-A441
Author(s):  
D JOHNSON ◽  
N VAKIL ◽  
C HWANG ◽  
J LEVINE

1970 ◽  
Author(s):  
J. Allan Burdick ◽  
Laverne C. Johnson ◽  
James W. Smith
Keyword(s):  

2018 ◽  
Vol 63 (4) ◽  
pp. 588-594
Author(s):  
Daniel W. Klyce ◽  
Kristin M. Graham ◽  
Russell W. Lacey ◽  
William E. Carter

1986 ◽  
Vol 55 (02) ◽  
pp. 173-177 ◽  
Author(s):  
K Desai ◽  
J S Owen ◽  
D T Wilson ◽  
R A Hutton

SummaryPlatelet aggregation, platelet lipid composition and plasma lipoprotein concentrations were measured each week in a group of seventeen alcoholics, without overt liver disease, for one month, following acute, total alcohol withdrawal. The platelets were initially hypoaggregable but, within 1-2 weeks of cessation of drinking, they became hyperaggregable and then gradually returned towards normal values. Hyperaggregability could not be explained by increases in either the cholesterol or the arachidonic acid content of the platelets. Plasma very-low-density lipoprotein cholesterol levels remained high throughout the study, but the initially raised levels of high-density lipoprotein (HDL) cholesterol fell by 26%. Low-density lipoprotein (LDL) cholesterol concentration rose by 10% after two weeks of withdrawal but then returned to about the starting level. The resulting changes in the plasma LDL-cholesterol: HDL-cholesterol ratio, which had increased by more than 50% after two weeks of abstinence, essentially paralleled the time course of enhanced platelet reactivity in all but four of the alcoholics. These findings suggest that alterations in plasma lipoprotein concentrations during acute alcohol withdrawal may be a contributory factor to the haemostatic disorders present in such patients.


1971 ◽  
Vol 32 (1) ◽  
pp. 104-115 ◽  
Author(s):  
S. M. Rosenblatt ◽  
M. M. Gross ◽  
Melinda Broman ◽  
Eastlyn Lewis ◽  
Beverly Malenowski

1958 ◽  
Vol 19 (1) ◽  
pp. 118-124 ◽  
Author(s):  
Lincoln Godfrey ◽  
Martin D. Kissen ◽  
Thomas M. Downs

2017 ◽  
Author(s):  
Ross Jack ◽  
Paul Fineron ◽  
Dilip Patel ◽  
Stuart Ritchie ◽  
Deepak Subedi ◽  
...  

2016 ◽  
Vol 10 (1) ◽  
pp. 26
Author(s):  
Pragnesh Parikh ◽  
◽  
KL Venkatachalam ◽  

Atrial fibrillation (AF) is the most common arrhythmia noted in clinical practice and its incidence and prevalence are on the rise. The single most important intervention is the evaluation and treatment of stroke risk. Once the risk for stroke has been minimized, controlling the ventricular rate and treating symptoms become relevant. In this review article, we emphasize the importance of confirming and treating the appropriate arrhythmia and correlating symptoms with rhythm changes. Furthermore, we evaluate some of the risk factors for AF that independently result in symptoms, underlining the need to treat these risk factors as part of symptom control. We then discuss existing and novel approaches to rate control in AF and briefly cover rhythm control methods.


1998 ◽  
Vol 7 (3) ◽  
pp. 189-197 ◽  
Author(s):  
Richard N. Rosenthal ◽  
Charles Perkel ◽  
Prameet Singh ◽  
Om Anand ◽  
Christian R. Miner

Sign in / Sign up

Export Citation Format

Share Document